XML 38 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Oct. 31, 2015
Oct. 31, 2014
Operating activities    
Net income $ 4,575 $ 80,354
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 5,052 4,405
Deferred income taxes 2,785 594
Provision for doubtful accounts receivable $ 873 44
Gain on sale of interest in Fabrix Systems Ltd. (75,145)
Realized (gain) loss on marketable securities $ (543) 40
Interest in the equity of investments 155 (1,898)
Stock-based compensation 771 848
Change in assets and liabilities:    
Restricted cash and cash equivalents 8,395 3,769
Trade accounts receivable (2,091) 7,364
Prepaid expenses, other current assets and other assets 2,352 2,937
Trade accounts payable, accrued expenses, other current liabilities and other liabilities (3,465) (9,766)
Customer deposits (4,985) (3,939)
Income taxes payable 148 (291)
Deferred revenue (69) (1,025)
Net cash provided by operating activities 13,953 8,291
Investing activities    
Capital expenditures (5,519) (6,111)
Proceeds from sale of interest in Fabrix Systems Ltd., net of cash and cash equivalents sold. 4,769 36,039
Purchase of investments   (218)
Proceeds from sale and redemption of investments 17 23
Purchases of marketable securities (14,911) (9,065)
Proceeds from maturities and sales of marketable securities 8,861 6,818
Net cash (used in) provided by investing activities (6,783) 27,486
Financing activities    
Dividends paid (4,199) (3,950)
Distributions to noncontrolling interests (600) (750)
Repayments of revolving credit loan payable and other borrowings (6,353) (13,065)
Repurchases of Class B common stock (23) (559)
Net cash used in financing activities (11,175) (18,324)
Effect of exchange rate changes on cash and cash equivalents (884) (3,074)
Net (decrease) increase in cash and cash equivalents (4,889) 14,379
Cash and cash equivalents at beginning of period 110,361 153,823
Cash and cash equivalents at end of period $ 105,472 168,202
Supplemental schedule of non-cash investing and financing activities    
Net liabilities excluding cash and cash equivalents of Fabrix Systems Ltd. sold   $ 14,333